Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [328]
News [959]
Articles [59]
Editorials [5]
Conferences [55]
elearning [4]
Venetoclax plus navitoclax in R/R ALL and lymphoblastic lymphoma
Dr Elias Jabbour - MD Anderson Cancer Center, Houston, USA
Venetoclax plus navitoclax in R/R ALL and lymphoblastic lymphoma ( Dr Elias Jabbour - MD Anderson Cancer Center, Houston, USA )
3 Jul 2020
The paediatric precision oncology study INFORM: Clinical outcome and benefit for...
Dr Cornelis van Tilburg - Hopp Children's Cancer Center Heidelberg, Heidelberg, ...
The paediatric precision oncology study INFORM: Clinical outcome and benefit for molecular subgroups ( Dr Cornelis van Tilburg - Hopp Children's Cancer Center Heidelberg, Heidelberg, Germany )
30 May 2020
COVID-19: Managing paediatric patients under the COVID pandemic
Dr Carmen Ballestas - Memorial Healthcare System, Florida, Miami
COVID-19: Managing paediatric patients under the COVID pandemic ( Dr Carmen Ballestas - Memorial Healthcare System, Florida, Miami )
4 May 2020
Updates in treating NTRK fusion cancer: Highlights from ESMO 2019
Prof Marc Peeters and Prof Jesus Garcia-Foncillas
Updates in treating NTRK fusion cancer: Highlights from ESMO 2019 ( Prof Marc Peeters and Prof Jesus Garcia-Foncillas )
9 Mar 2020
Indian Pediatric Oncology Group (InPOG)
Dr. Ramandeep Arora - Max Institute of Cancer Care, Saket, New Delhi, India
Indian Pediatric Oncology Group (InPOG) ( Dr. Ramandeep Arora - Max Institute of Cancer Care, Saket, New Delhi, India )
20 Feb 2020
Outcomes in paediatric oncology: Are we closing the gap between LMICs and high-i...
Prof Laila Hessissen - Mohammed V University of Rabat, Rabat, Morocco
Outcomes in paediatric oncology: Are we closing the gap between LMICs and high-income countries? ( Prof Laila Hessissen - Mohammed V University of Rabat, Rabat, Morocco )
7 Feb 2020
CAR-T cell therapy for ALL: Current challenges and future approaches
Dr Sara Ghorashian - University College London, London, UK
CAR-T cell therapy for ALL: Current challenges and future approaches ( Dr Sara Ghorashian - University College London, London, UK )
23 Jan 2020
CART-T cell therapy in young patients with relapsed/refractory ALL
Prof Peter Bader - Universitätsklinikum Frankfurt, Frankfurt, Germany
CART-T cell therapy in young patients with relapsed/refractory ALL ( Prof Peter Bader - Universitätsklinikum Frankfurt, Frankfurt, Germany )
23 Jan 2020
The role of blinatumomab followed by HSCT in paediatric patients with ALL
Prof Franco Locatelli - Ospedale Pediatrico Bambino Gesù, Rome, Italy
The role of blinatumomab followed by HSCT in paediatric patients with ALL ( Prof Franco Locatelli - Ospedale Pediatrico Bambino Gesù, Rome, Italy )
23 Jan 2020
Long-term toxicities in paediatric ALL
Prof Kjeld Schmiegelow - University of Copenhagen, Copenhagen, Denmark
Long-term toxicities in paediatric ALL ( Prof Kjeld Schmiegelow - University of Copenhagen, Copenhagen, Denmark )
23 Jan 2020
Frontline therapy of ALL
Prof Hervé Dombret - University Paris Diderot, Paris, France
Frontline therapy of ALL ( Prof Hervé Dombret - University Paris Diderot, Paris, France )
23 Jan 2020
BiTE therapy followed by HSCT vs CAR-T cells in young patients with R/R ALL
Prof Hervé Dombret - University Paris Diderot, Paris, France
BiTE therapy followed by HSCT vs CAR-T cells in young patients with R/R ALL ( Prof Hervé Dombret - University Paris Diderot, Paris, France )
23 Jan 2020

More from ecancer

Stay up to date with our ecancer newsletter

Learn more

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

Learn more

Support ecancer's work by making a donation